Related references
Note: Only part of the references are listed.Neurokinin-1 Receptor (NK1-R) Expression in the Brains of SIV-Infected Rhesus Macaques Implications for Substance P in NK1-R Immune Cell Trafficking into the CNS
Heather Vinet-Oliphant et al.
AMERICAN JOURNAL OF PATHOLOGY (2010)
Substance P Signaling Contributes to Granuloma Formation in Taenia crassiceps Infection, a Murine Model of Cysticercosis
Armandina Garza et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
TGF-β regulates T-cell neurokinin-1 receptor internalization and function
Martin Beinborn et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Substance P (SP) enhances CCL5-induced chemotaxis and intracellular signaling in human monocytes, which express the truncated neurokinin-1 receptor (NK1R)
Irene Chernova et al.
JOURNAL OF LEUKOCYTE BIOLOGY (2009)
Histoplasma capsulatum Encodes a Dipeptidyl Peptidase Active against the Mammalian Immunoregulatory Peptide, Substance P
Kendal G. Cooper et al.
PLOS ONE (2009)
Endosomes: A legitimate platform for the signaling train
Jane E. Murphy et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Neurokinin 1 receptor isoforms and the control of innate immunity
Florin Tuluc et al.
TRENDS IN IMMUNOLOGY (2009)
Elevated substance p levels in HIV-Infected women in comparison to HIV-Negative women
Steven D. Douglas et al.
AIDS RESEARCH AND HUMAN RETROVIRUSES (2008)
Neurokinin-1 Receptor Expression and Function in Human Macrophages and Brain Perspective on the Role in HIV Neuropathogenesis
Steven D. Douglas et al.
Neural Signaling: Opportunities for Novel Diagnostic Approaches and Therapies (2008)
Neurobiology of addiction - An integrative review
Aviel Goodman
BIOCHEMICAL PHARMACOLOGY (2008)
Neurogenic exacerbation of microglial and astrocyte responses to Neisseria meningitidis and Borrelia burgdorferi
Vinita S. Chauhan et al.
JOURNAL OF IMMUNOLOGY (2008)
Neurokinin-1 Receptor Antagonist (Aprepitant) Suppresses HIV-1 Infection of Microglia/Macrophages
Xu Wang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2008)
Detection of full-length and truncated neurokinin-1 receptor mRNA expression in human brain regions
Jian-Ping Lai et al.
JOURNAL OF NEUROSCIENCE METHODS (2008)
SUBSTANCE P RECEPTOR ANTAGONISM FOR TREATMENT OF CRYPTOSPORIDIOSIS IN IMMUNOSUPPRESSED MICE
Prema Robinson et al.
JOURNAL OF PARASITOLOGY (2008)
Neurokinin-1 receptor mRNA expression differences in brains of HIV-infected individuals
Steven D. Douglas et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
Drug therapy: Chemotherapy-induced nausea and vomiting
Paul J. Hesketh
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Differences in the length of the carboxyl terminus mediate functional properties of neurokinin-1 receptor
Jian-Ping Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Functional consequences of alteration of N-linked glycosylation sites on the neurokinin 1 receptor
Morris F. Tansky et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Neurokinin-1 receptor antagonist (aprepitant) inhibits drug-resistant HIV-1 infection of macrophages in vitro
Xu Wang et al.
JOURNAL OF NEUROIMMUNE PHARMACOLOGY (2007)
Substance P receptor mediated maintenance of chronic inflammation in EAE
Emily K. Reinke et al.
JOURNAL OF NEUROIMMUNOLOGY (2006)
Characterization of the gene structures, precursor processing and pharmacology of the endokinin peptides
Nigel M. Page
VASCULAR PHARMACOLOGY (2006)
The role of substance P in stress and anxiety responses
K. Ebner et al.
AMINO ACIDS (2006)
Overview of the primary structure, tissue-distribution, and functions of tachykinins and their receptors
Honoo Satake et al.
CURRENT DRUG TARGETS (2006)
Tachykinins and their receptors in human malignancies
Carla Palma
CURRENT DRUG TARGETS (2006)
Full-length and truncated neurokinin-1 receptor expression and function during monocyte/macrophage differentiation
J. -P. Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Tachykinins in the emerging immune system: Relevance to bone marrow homeostasis and maintenance of hematopoietic stem cells
SJ Greco et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
A non-peptide substance P antagonist (CP-96,345) inhibits morphine-induced NF-κB promoter activation in human NT2-N neurons
X Wang et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2004)
Tachykinins and tachykinin receptors: a growing family
JN Pennefather et al.
LIFE SCIENCES (2004)
Demonstration of the efficacy and safety of a novel substance P (NK1) receptor antagonist in major depression
MS Kramer et al.
NEUROPSYCHOPHARMACOLOGY (2004)
Tachykinin-modulated anti-viral responses
KL Bost
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Tachykinin-mediated modulation of the immune response
KL Bost
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
The role of tachykinins on bacterial infections
DW Pascual
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Non-neuronal mammalian tachykinin expression
DA Nelson et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2004)
Tachykinins and tachykinin receptors:: Structure and activity relationships
TA Almeida et al.
CURRENT MEDICINAL CHEMISTRY (2004)
Substance P and neurokinin-1 receptor modulation of HIV
WZ Ho et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Contribution of respiratory syncytial virus G antigenicity to vaccine-enhanced illness and the implications for severe disease during primary respiratory syncytial virus infection
TR Johnson et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2004)
The role of substance P in inflammatory disease
TM O'Connor et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2004)
Cutting edge: Hemokinin has substance P-like function and expression in inflammation
A Metwali et al.
JOURNAL OF IMMUNOLOGY (2004)
Identification of single-nucleotide polymorphisms of the human neurokinin 1 receptor gene and pharmacological characterization of a Y192H variant
GP Randolph et al.
PHARMACOGENOMICS JOURNAL (2004)
Expression of hemokinin 1 mRNA by murine dendritic cells
DA Nelson et al.
JOURNAL OF NEUROIMMUNOLOGY (2004)
Newly discovered tachykinins raise new questions about their peripheral roles and the tachykinin nomenclature
R Patacchini et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Virokinin, a bioactive peptide of the tachykinin family, is released from the fusion protein of bovine respiratory syncytial virus
G Zimmer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Clinical and neuroinflammatory responses to meningoencephalitis in substance P receptor knockout mice
PGE Kennedy et al.
BRAIN (2003)
Immunomodulatory effects of sensory nerves during respiratory syncytial virus infection in rats
A Auais et al.
AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY (2003)
Neurokinin 1 receptor and relative abundance of the short and long isoforms in the human brain
L Caberlotto et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2003)
Cloning of a C-terminally truncated NK-1 receptor from guinea-pig nervous system
SJ Baker et al.
MOLECULAR BRAIN RESEARCH (2003)
Reduced CTL response and increased viral burden in substance P receptor-deficient mice infected with murine γ-herpesvirus 68
SF Elsawa et al.
JOURNAL OF IMMUNOLOGY (2003)
Human neuronal cells (NT2-N) express functional substance P and neurokinin-1 receptor coupled to MIP-1β expression
Y Li et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2003)
Mutations in the extracellular amino-terminal domain of the NK2 neurokinin receptor abolish cAMP signaling but preserve intracellular calcium responses
S Lecat et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection
DL Evans et al.
AMERICAN JOURNAL OF PSYCHIATRY (2002)
A non-peptide substance P antagonist down-regulates SP mRNA expression in human mononuclear phagocytes
JP Lai et al.
JOURNAL OF NEUROIMMUNOLOGY (2002)
The tachykinin peptide family
C Severini et al.
PHARMACOLOGICAL REVIEWS (2002)
New insights into the antidepressant actions of substance P (NK1 receptor) antagonists
NMJ Rupniak
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY (2002)
The neurokinin A receptor activates calcium and cAMP responses through distinct conformational states
T Palanche et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Two active molecular phenotypes of the tachykinin NK1 receptor revealed by G-protein fusions and mutagenesis
B Holst et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Assessment of the role of the inositol 1,4,5-trisphosphate receptor in the activation of transient receptor potential channels and store-operated Ca2+ entry channels
HT Ma et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Substance P antagonist (CP-96,345) inhibits HIV-1 replication in human mononuclear phagocytes
JP Lai et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Exaggerated neurogenic inflammation and substance p receptor upregulation in RSV-infected weanling rats
KA King et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2001)
Update on substance P (NK-1 receptor) antagonists in clinical trials for depression
MS Kramer
NEUROPEPTIDES (2000)
The proliferative and antiapoptotic effects of substance P are facilitated by formation of a β-arrestin-dependent scaffolding complex
KA DeFea et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Human stem cells express substance P gene and its receptor
Y Li et al.
JOURNAL OF HEMATOTHERAPY & STEM CELL RESEARCH (2000)
Detection of substance P and its receptor in human fetal microglia
JP Lai et al.
NEUROSCIENCE (2000)
Share Paper
